Novel immunotherapeutic target against hepatocellular carcinoma



Novel immunotherapeutic target against hepatocellular carcinoma

Researchers have discovered the role of an isoformic programmed cell death protein 1 (PD-1) in suppressing the function of killer T cells, which is a type of immune cells essential for killing cancer cells among hepatocellular carcinoma (HCC) patients.

Materials provided by The University of Hong Kong. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

1st June 2023

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Read more
31st May 2023

Plants remove cancer causing toxins from air

Read more
31st May 2023

How the flu virus hacks our cells

Read more